+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Insight 2026

  • ID: 5406458
  • Report
  • August 2021
  • Region: Europe
  • 600 Pages
  • Kuick Research
UP TO OFF
until Dec 31st 2021

FEATURED COMPANIES

  • Accord Healthcare
  • AstraZeneca
  • Eli Lilly & Company
  • Mylan Pharmaceuticals
  • Pfizer
  • Takeda Pharmaceuticals

“Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Insight 2026” Report highlights:

  • Europe Biosimilars Market Opportunity: > USD 10 Billion
  • Dosage & Pricing insight On Approved Biosimilars
  • Biosimilars for Cancers Accounts for > 20% Market
  • Biosimilars for Diabetes Accounts for > 5% Market
  • Biosimilars Approval & Commercialization by Country
  • Insight On Biosimilar Clinical Trials By Company, Indication & Phase: > 100 Biosimilars
  • Insight On Commercially available Biosimilars in Market: > 25 Biosimilars
  • Biosimilar Market Trends by Country

Biopharmaceutical drugs have become an important part of modern pharmacotherapy. In recent times, biological drugs have comprised about 50% of the overall therapeutic market owing to their high efficacy and specificity in the management of wide range of diseases. However, the high cost of treatment associated with them possesses a significant burden on the healthcare systems.  The patent expiration of the biologic drugs has led to the development of biosimilar which aim to reduce the cost of treatment thus increasing the accessibility of the medications to the patients. 

Presently, there are 69 biosimilars in Europe that have been approved in clinics for a wide range of diseases including arthritis, cancer, inflammatory and auto-immune disorders. The European biosimilar market was the first to be established and still represents the most mature and advancing market at a global scale owing to a large number of approved and commercially available biosimilars. Adalimumab (Humira) is currently dominating the market which is due to high adoption rates of this drug associated with large number of biosimilar approval. Apart from this, several biosimilars for one reference product has been approved which increases the competition in the market. Adalimumab faces majority of competition with 6 biosimilars approved followed by Trastuzumab and Mabthera with five biosimilars competing with the reference product in the market. 

Since the launch of first biosimilar in Europe, the biosimilar market is continuously evolving and showing high adoption rates. The region represents an excellent market for the growth of biosimilars due to the presence of large pharmaceutical sector which actively indulge in research and development activities. The biosimilar market in Europe is highly competitive, with many key players dominating the market landscape including Novartis, Celltrion, Accord Healthcare, Pfizer and Mylan. Most of the key players are adopting various growth strategies, such as acquisitions, partnerships and new product launches to increase their revenue. 

Currently, the market is mainly dominated by UK which is mainly due to technological advancements in the healthcare care and healthcare spending. Regions including Denmark, Italy, France, and Germany are other lucrative markets and are expected high growth rates during the forecast period. Among the European countries, Denmark has been outstanding for its biosimilar consumption. Moreover, Denmark has also implemented one of the most radical biosimilar programs and produced a considerable amount of share in the overall biosimilar volume.
 
As per “Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Insight 2026” report findings, the Europe biosimilar market opportunity is expected to surpass US$ 10 10 Billion by 2026. The high rate in the market is mainly due to the rising demand for biosimilars due to their cost saving potential. In addition, the rising geriatric population in the region is also boosting the growth of the European Biosimilar market. Moreover, an increase in the burden on lifestyle diseases and the proliferation of chronic diseases including diabetes, cancer, asthma, arthritis and others, influence the biosimilar market during the forecast period. Furthermore, in the coming years the patent of several drugs including Cimzia, Yervoy, Lemtrada, Lucentis and others are expected to expire during the forecast period, which will further propel the development of biosimilars in Europe. 

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Accord Healthcare
  • AstraZeneca
  • Eli Lilly & Company
  • Mylan Pharmaceuticals
  • Pfizer
  • Takeda Pharmaceuticals

1. Introduction to Europe Biosimilar Market

2. Development of Biosimilars in Europe
2.1 Development of First Biosimilar Omnitrope: Genotropin
2.2 Second Wave of Biosimilars Development in Europe

3. Significance of Biosimilars in Europe Pharmaceutical Market

4. Off Patents: Biosimilar Opportunity Ahead

5. Europe Biosimilars Approval & Commercialization by Country

6. EMA Approved & Marketed Cancer Biosimilars: Dosage & Price Analysis
6.1 Biosimilars of Bevacizumab
6.2 Biosimilar to MabThera
6.3 Biosimilar of Trastuzumab

7. EMA Approved & Marketed Biosimilars in Blood Disorders: Dosage & Price Analysis
7.1 Biosimilar of Filgrastim
7.2 Biosimilar of Pegfilgrastim
7.3 Biosimilar of Enoxaparin Sodium

8. EMA Approved & Marketed Biosimilars in Diabetes: Dosage & Price Analysis
8.1 Biosimilar of Insulin Glargine
8.2 Biosimilar of Insulin Aspartate
8.3 Biosimilar of Insulin Lispro

9. EMA Approved & Marketed Biosimilars in Chronic Autoimmune Diseases: Dosage & Price Analysis
9.1 Biosimilar of Adalimumab
9.2 Biosimilar of Etanercept
9.3 Biosimilar of Infliximab

10. EMA Approved & Marketed Biosimilars in Other Therapeutic Indications: Dosage & Price Analysis
10.1 Biosimilar of Teriparatide
10.2 Biosimilar of Somatropin
10.3 Biosimilar of Follitropin Alfa
10.4 Biosimilar of Epoetin Alfa

11. Europe Biosimilar Market Insight
11.1 Market Overview
11.2 Current Market Scenario

12. Europe Biosimilar Market by Indication
12.1 Cancer
12.2 Autoimmune Diseases
12.3 Diabetes
12.4 Blood Disorders

13. Europe Biosimilar Clinical Trials By Company, Indication & Phase
13.1 Unknown
13.2 Research
13.3 Clinical
13.4 Phase-I
13.5 Phase-III
13.6 Preregistration
13.7 Registered

14. Europe Marketed Biosimilar Clinical Insight By Company, Drug Class & Indication

15. European Biosimilar Market Trends by Country
15.1 Austria
15.2 Belgium
15.3 Hungary
15.4 Italy
15.5 Norway
15.6 Poland
15.7 Spain
15.8 Sweden
15.9 Switzerland
15.10 UK
15.11 Germany
15.12 France
15.13 Denmark

16. Europe Vs. Global Biosimilar Market Scenarios
16.1 Europe vs. US Biosimilar Market
16.2 Europe vs. India Biosimilar Market
16.3 Europe vs. China Biosimilar Market
16.4 Europe vs. Japan Biosimilar Market
16.5 Europe vs. South Korea Biosimilar Market

17. Europe Biosimilar Market Dynamics
17.1 Favorable Market Parameters
17.2 Europe Biosimilar Market Challenges

18. Europe Biosimilar Market Future Prospects

19. Competitive Landscape
19.1 Accord Healthcare
19.2 Amgen
19.3 AstraZeneca
19.4 Boehringer Ingelheim
19.5 Eli Lilly & Company
19.6 Merck
19.7 Mylan Pharmaceuticals
19.8 Novartis
19.9 Pfizer
19.10 Sanofi
19.11 Takeda Pharmaceuticals
19.12 Teva Pharmaceutical

List of Figures
Figure 1-1: Europe - Approved Biosimilars by Indication
Figure 2-1: Early Development of First Biosimilar in Europe
Figure 2-2: EMA Approved Biosimilars, 2016-2020
Figure 2-3: EMA Approved Biosimilars by Reference Product’2021
Figure 2-4: EMA Approved Biosimilars by Therapeutic Indication, 2021
Figure 3-1: Significance of Biosimilars in Europe Biopharmaceutical Market
Figure 4-1: Europe - Ipilimumab EU Approval & Patent Expiration Year
Figure 4-2: Europe - Alemtuzumab EU Approval & Patent Expiration Year
Figure 4-3: Europe - Ranibizumab EU Approval & Patent Expiration Year
Figure 4-4: Europe - Ustekinumab EU Approval & Patent Expiration Year
Figure 4-5: Europe - Denosumab EU Approval & Patent Expiration Year
Figure 5-1: Europe - Biosimilars Approved in Different Therapeutic Class
Figure 6-1: Bevacizumab - Branded & Biosimilar EMA Approval Year
Figure 6-2: UK - Cost of 4ml Aybintio 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-3: UK - Cost of 16ml Aybintio 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-4: Denmark - Cost of 4ml Aybintio 100mg/4ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-5: Denmark - Cost of 16ml Aybintio 400mg/16ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-6: Netherlands - Cost of 4ml Aybintio 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-7: Netherlands - Cost of 16ml Aybintio 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-8: Germany - Cost of 4ml Aybintio 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-9: Germany - Cost of 16ml Aybintio 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-10: Germany - Cost of 4ml Mvasi 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-11: Germany - Cost of 16ml Mvasi 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-12: Denmark - Cost of 4ml Mvasi 100mg/4ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-13: Denmark - Cost of 16ml Mvasi 400mg/16ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-14: Netherlands - Cost of 4ml Mvasi 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-15: Netherlands - Cost of 16ml Mvasi 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-16: UK - Cost of 4ml Zirabev 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-17: UK - Cost of 16ml Zirabev 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-18: Denmark - Cost of 4ml Zirabev 100mg/4ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-19: Denmark - Cost of 16ml Zirabev 400mg/16ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-20: Netherlands - Cost of 4ml Zirabev 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-21: Netherlands - Cost of 16ml Mvasi 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-22: Germany - Cost of 4ml Zirabev 100mg/4ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-23: Germany - Cost of 16ml Zirabev 400mg/16ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-24: Bevacizumab - Recommended Initial Dose by Cancer Types (mg/kg)
Figure 6-25: MabThera - Branded & Biosimilar EMA Approval Year
Figure 6-26: UK - Cost of 50ml Truxima 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-27: UK - Cost of 2 Vials of Truxima 100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-28: Germany - Cost of 50ml Truxima 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-29: Germany - Cost of 2 Vials of Truxima 100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-30: Netherlands - Cost of 50ml Truxima 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-31: Netherlands - Cost of 50ml Truxima 100mg/10ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-32: UK - Cost of 2 Vials of Rixathon 100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-33: UK - Cost of 2 Vials of Rixathon 100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-34: Germany - Cost of 2 Vials of Rixathon 100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-35: Germany - Cost of 2 Vials of Rixathon 100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-36: Netherlands - Cost of 50ml Rixathon500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-37: Netherlands - Cost of 50ml Rixathon100mg/10ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-38: Denmark- Cost of 50ml Rixathon500mg/50ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-39: Denmark - Cost of 2 Vials of Rixathon 100mg/10ml Solution & Per Unit Cost of Vial (DKK/US$), July’2021
Figure 6-40: Germany - Cost of 50ml Blitzima 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-41: Germany - Cost of 2 Vials of Blitzima100mg/10ml Solution & Per Unit Cost of Vial (Euro/US$), July’2021
Figure 6-42: Denmark- Cost of 50ml Ritemvia 500mg/50ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-43: Denmark - Cost of 2 Vials of Ritemvia 100mg/10ml Solution & Per Unit Cost of Vial (DKK/US$), July’2021
Figure 6-44: Netherlands - Cost of 50ml Ruxience 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-45: Netherlands - Cost of 50ml Ruxience 100mg/10ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-46: Germany - Cost of 50ml Ruxience 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-47: Germany - Cost of 50ml Ruxience 100mg/10ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-48: UK - Cost of 50ml Ruxience 500mg/50ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-49: UK - Cost of 10ml Ruxience 100mg/10ml Solution & Per Unit Cost of Solution (Euro/US$), July’2021
Figure 6-50: Denmark - Cost of 50ml Ruxience 500mg/50ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-51: Denmark - Cost of 10ml Ruxience 100mg/10ml Solution & Per Unit Cost of Solution (DKK/US$), July’2021
Figure 6-52: Trastuzumab - Branded & Biosimilar EMA Approval Year
Figure 6-53: UK - Cost of Ontruzant 150mg Powder (Euro/US$), July’2021
Figure 6-54: Denmark - Cost of Ontruzant 420mg Powder (DKK/US$), July’2021
Figure 6-55: Germany - Cost of 150mg & 420mg Ontruzant Powder (Euro/US$), July’2021
Figure 6-56: Netherlands - Cost of 150mg & 420mg Ontruzant Powder (Euro/US$), July’2021
Figure 6-57: UK - Cost of 150mg & 420mg Herzuma Powder (Euro/US$), July’2021
Figure 6-58: Germany - Cost of 150mg & 420mg Herzuma Powder (Euro/US$), July’2021
Figure 6-59: Netherland - Cost of 150mg & 420mg Herzuma Powder (Euro/US$), July’2021
Figure 6-60: UK - Cost of 150mg & 420mg Trazimera Powder (Euro/US$), July’2021
Figure 6-61: Netherland - Cost of 150mg & 420mg Trazimera Powder (Euro/US$), July’2021
Figure 6-62: Germany - Cost of 150mg & 420mg Trazimera Powder (Euro/US$), July’2021
Figure 6-63: Denmark - Cost of 150mg & 420mg Trazimera Powder (DKK/US$), July’2021
Figure 6-64: UK - Cost of 150mg & 420mg Kanjinti Powder (Euro/US$), July’2021
Figure 6-65: Germany - Cost of 150mg & 420mg Herzuma Powder (Euro/US$), July’2021
Figure 6-66: Netherland - Cost of 150mg & 420mg Kanjinti Powder (Euro/US$), July’2021
Figure 6-67: UK - Cost of Zercepac 150mg Powder (Euro/US$), July’2021
Figure 6-68: Germany - Cost of Zercepac 150mg Powder (Euro/US$), July’2021
Figure 6-69: Netherland - Cost of Zercepac 150mg Powder (Euro/US$), July’2021
Figure 6-70: Trastuzumab - Recommended Initial & Maintenance Dose by Cancer Types (mg/kg)
Figure 7-1: Filgrastim - Biosimilar EMA Approval Year by Brand
Figure 7-2: Germany - Cost of 5 Pre-Filled Ratiograstim 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-3: Germany - Cost of 5 Pre-Filled Ratiograstim 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-4: Germany - Cost of 5 Pre-Filled Tevagrastim 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-5: Germany - Cost of 5 Pre-Filled Tevagrastim 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-6: Netherland - Cost of Per Unit Pre-Filled Tevagrastim Disposable Pen by Strength (Euro/US$), July’2021
Figure 7-7: Germany - Cost of 5 Pre-Filled Filgrastim Hexal 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-8: Germany - Cost of 5 Pre-Filled Filgrastim Hexal 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-9: UK - Cost of 5 Pre-Filled Zarzio 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-10: UK - Cost of 5 Pre-Filled Zarzio 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-11: Germany - Cost of 5 Pre-Filled Zarzio 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-12: Germany - Cost of 5 Pre-Filled Zarzio 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-13: Netherland - Cost of Per Unit Pre-Filled Zarzio Disposable Pen by Strength (Euro/US$), July’2021
Figure 7-14: Denmark - Cost of 5 Pre-Filled Zarzio 48 million units/0.8ml Pen & Per Unit Price of Pen (DKK/US$), July’2021
Figure 7-15: Denmark - Cost of 5 Pre-Filled Zarzio 30 million units/0.5ml Pen & Per Unit Price of Pen (DKK/US$), July’2021
Figure 7-16: UK - Cost of 5 Pre-Filled Nivestim 12 million units/0.2ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-17: UK - Cost of 5 Pre-Filled Nivestim 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-18: UK - Cost of 5 Pre-Filled Nivestim 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-19: Germany - Cost of 5 Pre-Filled Nivestim 12 million units/0.2ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-20: Germany - Cost of 5 Pre-Filled Nivestim 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-21: Germany - Cost of 5 Pre-Filled Nivestim 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-22: Denmark - Cost of 5 Pre-Filled Nivestim 12 million units/0.2ml Pen & Per Unit Price of Pen (DKK/US$), July’2021
Figure 7-23: Netherland - Cost of Per Unit Pre-Filled Nivestim Disposable Pen by Strength (Euro/US$), July’2021
Figure 7-24: Germany - Cost of 5 Pre-Filled Grastofil 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-25: Germany - Cost of 5 Pre-Filled Grastofil 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-26: UK - Cost of 7, 5 Pre-Filled Nivestim 30 million units/0.5ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-27: UK - Cost of 7, 5 Pre-Filled Nivestim 48 million units/0.8ml Pen & Per Unit Price of Pen (Euro/US$), July’2021
Figure 7-28: Denmark - Cost of 5 Pre-Filled Accofil 30 million units/0.5ml Pen & Per Unit Price of Pen (DKK/US$), July’2021
Figure 7-29: Denmark - Cost of 5 Pre-Filled Accofil 48 million units/0.8ml Pen & Per Unit Price of Pen (DKK/US$), July’2021
Figure 7-30: Netherland - Cost of Per Unit Pre-Filled Accofil Disposable Pen by Strength (Euro/US$), July’2021
Figure 7-31: Filgrastim - Recommended Initial Dose by Indication (mcg/kg/day)
Figure 7-32: Filgrastim - Recommended Minimum & Maximum Dose for Congenital Neutropenia (mcg/kg/day)
Figure 7-33: Pegfilgrastim - Biosimilar EMA Approval Year by Brand
Figure 7-34: UK - Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (Euro/US$), July’2021
Figure 7-35: Denmark - Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (DKK/US$), July’2021
Figure 7-36: Germany - Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (Euro/US$), July’2021
Figure 7-37: Netherlands - Cost of Per Unit Pre-Filled Pelgraz 6mg/0.6ml Pen (Euro/US$), July’2021
Figure 7-38: Denmark - Cost of 0.6ml Pre-Filled Ziextenzo Pen & Per Unit (DKK/US$), July’2021
Figure 7-39: UK - Cost of 0.6ml Pre-Filled Ziextenzo Pen & Per Unit (Euro/US$), July’2021
Figure 7-40: Germany - Cost of 0.6ml Pre-Filled Ziextenzo Pen & Per Unit (Euro/US$), July’2021
Figure 7-41: Netherlands - Cost of 0.6ml Pre-Filled Ziextenzo Pen & Per Unit (Euro/US$), July’2021
Figure 7-42: UK - Cost of 0.6ml Pre-Filled Pelmeg Pen & Per Unit (Euro/US$), July’2021
Figure 7-43: Netherlands - Cost of 0.6ml Pre-Filled Ziextenzo Pen & Per Unit (Euro/US$), July’2021
Figure 7-44: Germany - Cost of 0.6ml Pre-Filled Ziextenzo Pen & Per Unit (Euro/US$), July’2021
Figure 7-45: Germany - Cost of 0.6ml Pre-Filled Grastutek Pen & Per Unit (Euro/US$), July’2021
Figure 7-46: Germany - Cost of 0.6ml Pre-Filled Cegfila Pen & Per Unit (Euro/US$), July’2021
Figure 7-47: Germany - Cost of 0.6ml Pre-Filled Nyvepria Pen & Per Unit (Euro/US$), July’2021
Figure 7-48: Pegfilgrastim - Recommended Dose for Pediatric Patients with Neutropenia (mcg/kg/day)
Figure 7-49: UK - Cost of 10 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021
Figure 7-50: Netherlands - Average Price Per Piece of Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021
Figure 7-51: Germany - Cost of 10 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021
Figure 7-52: Germany - Cost of 12 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021
Figure 7-53: Denmark - Cost of 10 Pre-Filled Inhixa Pens by Strength (Euro/US$), July’2021
Figure 7-54: Enoxaparin Sodium - Recommended Dose for Management of Myocardial Infarction by Age (mg/kg/day)
Figure 7-55: Enoxaparin Sodium - Recommended Pediatric Dose for Management of Deep Vein Thrombosis by Age (mg/kg/day)
Figure 7-56: Enoxaparin Sodium - Recommended Pediatric Dose for Management of Prophylaxis by Age (mg/kg/day)
Figure 8-1: Insulin Glargine: Branded & Biosimilar EMA Approval Year
Figure 8-2: Denmark - Cost of Abasaglar 5 Cartridges & Per Unit Price of 100Units/ml Cartridge (DKK/US$), July'2021
Figure 8-3: UK - Cost of Abasaglar 5 Cartridges & Per Unit Price of 100Units/ml Cartridge (Euro/US$), July'2021
Figure 8-4: Germany - Cost of Abasaglar 5 Cartridges & Per Unit Price of 100Units/ml Cartridge (Euro/US$), July'2021
Figure 8-5: Germany - Cost of Abasaglar 10 Cartridges & Per Unit Price of 100Units/ml Cartridge (Euro/US$), July'2021
Figure 8-6: Netherlands - Cost of Per Unit Price of Abasaglar 100Units/ml Cartridge (Euro/US$), July'2021
Figure 8-7: Denmark - Cost of Semglee 5 Cartridges & Per Unit Price of 100Units/ml Cartridge (DKK/US$), July'2021
Figure 8-8: UK - Cost of Semglee Pre-Filled Pens & Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021
Figure 8-9: Insulin Aspartate: Branded & Biosimilar EMA Approval Year
Figure 8-10: Denmark - Cost of 5 Insulin Aspart Pens & Per Unit Price of 100Units/ml Pen (DKK/US$), July'2021
Figure 8-11: Germany - Cost of 10 Insulin Aspart Pens & Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021
Figure 8-12: Insulin Lispro: Branded & Biosimilar EMA Approval Year
Figure 8-13: UK - Cost of 5 Lyumjev Pens & Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021
Figure 8-14: UK - Cost of 5 Lyumjev Pens & Per Unit Price of 200Units/ml Pen (Euro/US$), July'2021
Figure 8-15: Germany - Cost of 5 Lyumjev Pens & Per Unit Price of 100Units/ml Pen (Euro/US$), July'2021
Figure 8-16: Germany - Cost of 5 Lyumjev Pens & Per Unit Price of 200Units/ml Pen (Euro/US$), July'2021
Figure 9-1: Adalimumab: Branded & Biosimilar EMA Approval Year
Figure 9-2: Denmark - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution DKK/US$), July'2021
Figure 9-3: Denmark - Cost of 2 Pre-Filled Amgevita 40mg Injection & Per Unit Price of Injectable Solution (DKK/US$), July'2021
Figure 9-4: Germany - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution (Euro/US$), July'2021
Figure 9-5: Germany - Cost of 2 Pre-Filled Amgevita 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-6: Germany - Cost of 6 Pre-Filled Amgevita 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-7: UK - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution (Euro/US$), July'2021
Figure 9-8: UK - Cost of 2 Pre-Filled Amgevita 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-9: Netherlands - Cost of Per Unit Amgevita 20mg/0.4ml Injectable Solution (Euro/US$), July'2021
Figure 9-10: Netherlands - Cost of Per Unit Amgevita 40mg/0.8ml Injectable Solution (Euro/US$), July'2021
Figure 9-11: Germany - Cost of 2 Pre-Filled Hulio 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-12: Germany - Cost of 6 Pre-Filled Hulio 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-13: UK - Cost of 2 Pre-Filled Hulio 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-14: Netherlands - Cost of Per Unit Hulio 40mg/0.8ml Injectable Solution (Euro/US$), July'2021
Figure 9-15: Germany - Cost of 2 Pre-Filled Hyrimoz 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-16: Germany - Cost of 6 Pre-Filled Hyrimoz 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-17: UK - Cost of 2 Pre-Filled Hyrimoz 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-18: Denmark- Cost of 2 Pre-Filled Hyrimoz 40mg Injection & Per Unit Price of Injectable Solution (DKK/US$), July'2021
Figure 9-19: Netherlands - Cost of Per Unit Hyrimoz 40mg/0.8ml Injectable Solution (Euro/US$), July'2021
Figure 9-20: Netherlands - Cost of Per Unit Hyrimoz 20mg/0.4ml Injectable Solution (Euro/US$), July'2021
Figure 9-21: Germany - Cost of 2 Pre-Filled Idacio 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-22: Germany - Cost of 6 Pre-Filled Idacio 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-23: UK - Cost of 2 Pre-Filled Idacio 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-24: Netherlands - Cost of Per Unit Idacio 40mg/0.8ml Injectable Solution (Euro/US$), July'2021
Figure 9-25: Germany - Cost of 2 Pre-Filled Yuflyma 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-26: Germany - Cost of 6 Pre-Filled Yuflyma 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-27: Netherlands - Cost of Per Unit Yuflyma 40mg/0.8ml Injectable Solution (Euro/US$), July'2021
Figure 9-28: UK - Cost of 2 Pre-Filled Imraldi 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-29: Germany - Cost of 2 Pre-Filled Imraldi 40mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-30: Netherlands - Cost Per Unit Price of Imraldi 40mg/0.8ml Injectable Solution (Euro/US$), July'2021
Figure 9-31: Denmark - Cost of 2 Pre-Filled Imraldi 40mg Injection & Per Unit Price of Injectable Solution (DKK/US$), July'2021
Figure 9-32: Adalimumab - Recommended Dose for Adult Patients with Crohn's Disease, Hidradenitis Suppurativa & Ulcerative Colitis (mg)
Figure 9-33: Adalimumab - Recommended Dose for Adult Patients with Plaque Psoriasis & Uvetis (mg)
Figure 9-34: Adalimumab - Recommended Dose for Pediatric Patients with Juvenile Idiopathic Arthritis & Uvetis by Weight (mg)
Figure 9-35: Adalimumab - Recommended Dose for Pediatric Patients with Crohn's Disease, by Weight (mg)
Figure 9-36: Etanercept: Branded & Biosimilar Approval Year
Figure 9-37: UK - Cost of 4 Pre-Filled Benepali 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-38: UK - Cost of 4 Pre-Filled Benepali 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-39: Germany - Cost of 24 Pre-Filled Benepali 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-40: Germany - Cost of 4 Pre-Filled Benepali 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-41: Netherlands - Cost Per Unit Price of Benepali 50mg Injectable Solution (Euro/US$), July'2021
Figure 9-42: Denmark - Cost of 4 Pre-Filled Benepali 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-43: Denmark - Cost of 4 Pre-Filled Benepali 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-44: UK - Cost of 4 Pre-Filled Erelzi 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-45: UK - Cost of 4 Pre-Filled Erelzi 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-46: Germany - Cost of 4 Pre-Filled Erelzi 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-47: Germany - Cost of 4 Pre-Filled Erelzi 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-48: Netherlands - Cost Per Unit Price of Erelzi 50mg Injectable Solution (Euro/US$), July'2021
Figure 9-49: Denmark - Cost of 2 Pre-Filled Erelzi 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-50: Denmark - Cost of 4 Pre-Filled Erelzi 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-51: Germany - Cost of 4 Pre-Filled Nepexto 25mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-52: Germany - Cost of 4 Pre-Filled Nepexto 50mg Injection & Per Unit Price of Injectable Solution (Euro/US$), July'2021
Figure 9-53: Etanercept - Recommended Initial Dose by Indication (mg/weekly)
Figure 9-54: Infliximab: Branded & Biosimilar Approval Year
Figure 9-55: UK - Cost of 2 Remsima Vials & Per Unit Price of 120mg Vial (Euro/US$), July'2021
Figure 9-56: Netherlands - Average Per Unit Price of Remsima Vials by Strength (Euro/US$), July'2021
Figure 9-57: Germany - Cost of 2 Remsima Vials & Per Unit Price of 100mg Vial (Euro/US$), July'2021
Figure 9-58: Germany - Cost of 2 Remsima Vials & Per Unit Price of 120mg Vial (Euro/US$), July'2021
Figure 9-59: Inflectra - Average Price Per Unit of 100mg Inflectra by Region (Euro/US$), July'2021
Figure 9-60: Flixabi - Average Price Per Unit of 100mg Flixabi by Region (Euro/US$), July'2021
Figure 9-61: Denmark - Cost of 3 Flixabi Vials & Per Unit Price of 120mg Vial (DKK/US$), July'2021
Figure 9-62: Zessly - Average Price Per Unit of 100mg Zessly by Region (Euro/US$), July'2021
Figure 9-63: Denmark - Cost of 3 ZesslyVials & Per Unit Price of 100mg Vial (DKK/US$), July'2021
Figure 9-64: Infliximab - Recommended Initial Dose by Indication (mg/kg)
Figure 10-1: Teriparatide - Branded & Biosimilar EMA Approval Year
Figure 10-2: UK - Cost of 3 Terrosa 2.4ml Cartridges & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-3: Germany - Cost of 3 Terrosa 2.4ml Cartridges & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-4: Denmark - Cost of Terrosa 2.4ml Cartridges & Per Unit Price of Solution (DKK/US$), July’2021
Figure 10-5: UK - Cost of Movymia 2.4ml Cartridges & Per Unit Price of Solution (Euro/US$), July’2021
Figure 10-6: Netherland - Cost of Movymia 2.4ml Cartridges & Per Unit Price of Solution (Euro/US$), July’2021
Figure 10-7: Germany - Cost of Movymia 2.4ml Cartridges & Per Unit Price of Solution (Euro/US$), July’2021
Figure 10-8: Denmark - Cost of Movymia 2.4ml Cartridges & Per Unit Price of Solution (DKK/US$), July’2021
Figure 10-9: Germany - Cost of Livogiva 2.4ml Cartridges & Per Unit Price of Solution (Euro/US$), July’2021
Figure 10-10: Teriparatide - Recommended Daily, Monthly & Annual Dose for Osteoporosis (mcg)
Figure 10-11: Somatropin - Branded & Biosimilar EMA Approval Year
Figure 10-12: UK - Cost of 5 Omnitrope Cartridge of 5mg/1.5ml & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-13: UK - Cost of 5 Omnitrope Cartridge of 10mg/1.5ml & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-14: UK - Cost of 5 Omnitrope Cartridge of 15mg/1.5ml & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-15: Germany - Cost of 5 Omnitrope Cartridge of 5mg/1.5ml & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-16: Germany - Cost of 5 Omnitrope Cartridge of 10mg/1.5ml & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-17: Germany - Cost of 5 Omnitrope Cartridge of 15mg/1.5ml & Per Unit Price of Cartridge (Euro/US$), July’2021
Figure 10-18: Netherlands - Average Price Per Unit of Omnitrope Cartridge by Strength (Euro/US$), July’2021
Figure 10-19: Denmark - Cost of 5 Omnitrope Cartridge of 5mg/1.5ml & Per Unit Price of Cartridge (DKK/US$), July’2021
Figure 10-20: Denmark - Cost of 5 Omnitrope Cartridge of 10mg/1.5ml & Per Unit Price of Cartridge (DKK/US$), July’2021
Figure 10-21: Denmark - Cost of 5 Omnitrope Cartridge of 15mg/1.5ml & Per Unit Price of Cartridge (DKK/US$), July’2021
Figure 10-22: Somatropin - Recommended Pediatric Dose by Indication (mg/kg/week)
Figure 10-23: Somatropin - Recommended Minimum & Maximum Dose for Growth Hormone Deficiency by Age (mg/kg/week)
Figure 10-24: Follitropin - Branded & Biosimilar EMA Approval Year
Figure 10-25: UK - Cost Per Unit of Bemfola Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-26: Netherland - Cost Per Unit of Bemfola Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-27: Germany - Cost Per Unit of Bemfola Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-28: UK - Cost Per Unit of Ovaleap Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-29: Netherland - Cost Per Unit of Ovaleap Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-30: Germany - Cost Per Unit of Ovaleap Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-31: Denmark - Cost Per Unit of Ovaleap Pre-filled Pens by Strength (DKK/US$), July'2021
Figure 10-32: Follitropin Alfa - Recommended Minimum & Maximum Dose (IU/day)
Figure 10-33: Germany - Cost of 6 Abseamed Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-34: Netherlands - Average Cost Per Unit of Binocrit Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-35: Germany - Average Cost Per Unit of Epoetin Alfa Hexal Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-36: Germany - Cost of 6 Retacrit Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-37: UK- Cost of 6 Retacrit Pre-filled Pens by Strength (Euro/US$), July'2021
Figure 10-38: Epoetin Alfa - Recommended Initial Adult Dose for Anemia by Combination (units/kg)
Figure 10-39: Epoetin Alfa - Recommended Initial Pediatric Dose for Anemia by Combination (units/kg)
Figure 11-1: Europe - Geriatric Population (Million), 2019 & 2050
Figure 11-2: Europe - Approved Biosimilars by Status (%), July’2021
Figure 11-3: Europe - Biosimilar Market Size (US$ Billion), 2020-2026
Figure 12-1: US - Cancer Incidence & Mortality (Million), 2020 & 2040
Figure 12-2: Europe - Approved & Marketed Biosimilar by Indication (%), July’2021
Figure 12-3: Europe - Biosimilar Market Size by Indication (%), July’2021
Figure 12-4 Europe - Cancer Biosimilar Market Size (US$ Billion), 2020-2026
Figure 12-5: Europe - Approved & Marketed Biosimilar by Indication (%), July’2021
Figure 12-6: Europe - Biosimilar Market Size by Indication (%), July’2021
Figure 12-7: Europe - Autoimmune Diseases Biosimilar Market Size (US$ Billion), 2020-2026
Figure 12-8: Europe - Approved & Marketed Biosimilar by Indication (%), July’2021
Figure 12-9: Europe - Biosimilar Market Size by Indication (%), July’2021
Figure 12-10: Europe - Diabetes Biosimilar Market Size (US$ Billion), 2020-2026
Figure 12-11: Europe - Approved & Marketed Biosimilar by Indication (%), July’2021
Figure 12-12: Europe - Biosimilar Market Size by Indication (%), July’2021
Figure 12-13: Europe - Blood Disorder Biosimilar Market Size (US$ Million), 2020-2026
Figure 13-1: Europe - Number of Biosimilars in Clinical Trials by Phase, 2021 till 2026
Figure 13-2: Europe - Number of Biosimilars in Clinical Trials by Company, 2021 till 2026
Figure 13-3: Europe - Number of Biosimilars in Clinical Trials by Indication, 2021 till 2026
Figure 13-4: Europe - Number of Biosimilars in Clinical Trials by Patient Segment, 2021 till 2026
Figure 15-1: Belgium - Biosimilars Market Share by Volume, 2019
Figure 15-2: Spain - Cumulative Savings by Biosimilar (Euro/US$ Million), 2009-2019
Figure 15-3: UK - Cancer Biosimilar Market Size (US$ Million), 2020-2026
Figure 15-4: Germany - Cost Saving Potential of Biosimilar by Product (US$ Million), 2020
Figure 15-5 - France: Causes of Mortality by Gender (%), 2020
Figure 15-6: France - Biosimilar Market Size (US$ Million), 2020-2026
Figure 16-1: Approved Biosimilars - Europe vs. US
Figure 16-2: Approved & Marketed Biosimilar - Europe vs. US
Figure 16-3: Biosimilars Approved for Product - Europe vs. US
Figure 16-4: US - Biosimilar Market Size (US$ Billion), 2020-2026
Figure 16-5: Approved Biosimilar - Europe vs. India
Figure 16-6: First Approved Biosimilar - Europe vs. India
Figure 16-7: India - Biosimilar Clinical Pipeline by Status, 2019
Figure 16-8: India - Biosimilar Clinical Pipeline by Status (%), 2019
Figure 16-9: China - Biological Drugs Market Size (US$/Yuan Billion), 2020-2026
Figure 16-10: Approved Biosimilars - Europe vs. China
Figure 16-11: First Approved Biosimilar - Europe vs. China
Figure 16-12: Approved Biosimilars - Europe vs. Japan
Figure 16-13: First Approved Biosimilar - Europe vs. Japan
Figure 16-14: Biosimilars Approved for Product: Europe vs. Japan
Figure 16-15: Japan - Biosimilar Market Size (US$ Million), 2020-2026
Figure 16-16: Approved Biosimilars - Europe vs. South Korea
Figure 16-17: First Approved Biosimilar - Europe vs. South Korea
Figure 17-1: Europe - Biosimilar Market Favorable Parameters
Figure 17-2: Europe - Biosimilar Market Challenges

Note: Product cover images may vary from those shown

Loading
LOADING...

A selection of companies mentioned in this report includes:

  • Accord Healthcare
  • Amgen
  • AstraZeneca
  • Boehringer Ingelheim
  • Eli Lilly & Company
  • Merck
  • Mylan Pharmaceuticals
  • Novartis
  • Pfizer
  • Sanofi
  • Takeda Pharmaceuticals
  • Teva Pharmaceutical
Note: Product cover images may vary from those shown
Adroll
adroll